Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wei-Chen Lin

Showing results (301-310 of 303) with videos related to

Pageof 31
Sort By:
You have reached the last page of results.This site can display upto 303 results.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 31, 2025
Acute Severe Ulcerative Colitis Patients From Asia Have Lower Colectomy Risk Than Patients From AustralasiaRichard Gareth Fernandes, Dong Hyun Kim, Leonie Ruddick-Collins, et al.
Inflammatory Bowel Diseases|January 10, 2023
Real-World Evidence of Effectiveness and Safety of Vedolizumab for Inflammatory Bowel Disease in Taiwan: A Prospective Nationwide Registry (VIOLET) StudyWei-Chen Lin, Wei-Chen Tai, Chung-Hsin Chang, et al.
The American Journal of Gastroenterology|September 5, 2018
Population Density and Risk of Inflammatory Bowel Disease: A Prospective Population-Based Study in 13 Countries or Regions in Asia-PacificSiew C Ng, Gilaad G Kaplan, Whitney Tang, et al.
Pageof 31

Showing results (301-310 of 303) with videos related to

Sort By:
Pageof 31
You have reached the last page of results.This site can display upto 303 results.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 31, 2025
Acute Severe Ulcerative Colitis Patients From Asia Have Lower Colectomy Risk Than Patients From AustralasiaRichard Gareth Fernandes, Dong Hyun Kim, Leonie Ruddick-Collins, et al.
Inflammatory Bowel Diseases|January 10, 2023
Real-World Evidence of Effectiveness and Safety of Vedolizumab for Inflammatory Bowel Disease in Taiwan: A Prospective Nationwide Registry (VIOLET) StudyWei-Chen Lin, Wei-Chen Tai, Chung-Hsin Chang, et al.
The American Journal of Gastroenterology|September 5, 2018
Population Density and Risk of Inflammatory Bowel Disease: A Prospective Population-Based Study in 13 Countries or Regions in Asia-PacificSiew C Ng, Gilaad G Kaplan, Whitney Tang, et al.
Pageof 31